Pittsburgh-based pharmaceutical research and development firm Cognition Therapeutics (CogRx) announced April 1 that the company’s patent for numerous drug therapy candidates have been approved.

Hypertension and other cardiovascular risk factors from early adulthood and beyond have a direct impact on future cognitive ability, according to a study published March 31 in Circulation.

The ongoing deposition of beta-amyloid in the aging brain is related to central arterial stiffness, according to a study published online March 31 in JAMA Neurology.

Samsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, today announced its first premium ultrasound system – the Samsung UGEO WS80A – designed to redefine ultrasound for women’s health. Combining Samsung’s latest medical imaging innovations and 5D technology, the Samsung UGEO WS80A is among a number of innovative medical imaging products Samsung is showcasing at the American Institute of Ultrasound in Medicine’s (AIUM) Annual Convention at Caesars Palace, Octavius Ballroom, Booth #301.   

Breast cancer metastases that have spread to the liver have been found to be treated successfully with yttrium-90 (Y-90) radioembolization, which led to stabilized disease in 98.5 percent of liver tumors, according to procedings of the Society of Interventional Radiology's 39th Annual Scientific Meeting held March 22-27 in San Diego.

First-in-human trial of Indium-111 ABY-025 affibody molecule SPECT imaging safely points out human epidermal growth factor receptor type 2 (HER2) expression in metastatic breast tumors, according to preliminary research published online March 24 in the Journal of Nuclear Medicine.

Pretreatment PET with F-18 FDG as well as MR imaging provides useful diagnostic data, with PET showing a particular edge for prognosis, according to a study published online March 24 in the Journal of Nuclear Medicine.

The office of the New York attorney general, Eric T. Scheiderman, released a statement earlier this month naming Lantheus Medical Imaging and Bristol-Myers Squib in a $6.2 million settlement for failing to pay corporate income taxes in New York.